researchintokyo.com

Japan Market Access

Japan Market Access

  • Home
  • Japan Market Access
    • Coverage Decisions
    • Pricing and Reimbursement
  • Approvals
    • List of New Drugs/Indications Approved in Japan in 2014
  • Services
    • Marketing Authorization
  • Blog
  • About Us
  • Contact Us

Recent Posts

  • Protected:
  • Anti-VEGF Battles: Eylea Overtakes Lucentis in Japan
  • iPS Cell Regenerative Medicine to Rely on Donor Cells in Order to Cut 77% of Costs
  • Plan: Generics to increase from 60% to 80% by 2017
  • Average Nursing Care Premium Breaks Through ¥5000

Coverage Decisions


RIT provides tailored consulting on coverage decisions for every approved pharmaceutical and medical device in Japan for the past 15 years.

Check this blog article for Zimmer’s Trabecular Metal Augments

For inquires on the topic, use the contact form.

 

 

Coverage decisions in Japan.

Coverage decisions in Japan.

· © 2025 researchintokyo.com · Designed by Press Customizr · Powered by ·